missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Thermo Scientific™ CaptureSelect™ Biotin Anti-AAV9 Conjugate
Thermo Scientific™ CaptureSelect™ Biotin Anti-AAV9 Conjugate consists of a 13 kDa recombinant single domain antibody fragment (VHH affinity ligand) that specifically binds with high affinity to adeno-associated virus particles of serotype 9 (AAV9).
514.00€ - 1802.00€
Spécification
| Contenu et stockage | Store in freezer (-5°C to -30°C). |
|---|---|
| Gamme de produits | CaptureSelect™ |
| Type de ligand | Antibody |
| Conditions d’expédition | Dry Ice |
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
|---|---|---|---|---|---|---|---|---|---|
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
|
18426478
|
Thermo Scientific™
7103332100 |
100 μg |
514.00€
100µg |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
|
18406598
|
Thermo Scientific™
7103332500 |
500 μg |
1802.00€
500µg |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
Description
CaptureSelect Biotin Anti-AAV9 Conjugate consists of a 13 kDa recombinant single domain antibody fragment (VHH affinity ligand) that specifically binds with high affinity to adeno-associated virus particles of serotype 9 (AAV9). The affinity ligand is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligand when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces. This conjugate allows you to detect, quantitate, and characterize AAV9 particles.
Applications for CaptureSelect Biotin Anti-AAV9 Conjugate include ELISA, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).
Animal origin statement
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12–15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Spécification
| Store in freezer (-5°C to -30°C). | |
| CaptureSelect™ | |
| Antibody | |
| Dry Ice |